By Andrew Scurria ( July 22, 2013, 7:45 PM EDT) -- The Third Circuit on Monday revived accusations that GlaxoSmithKline LLC provided Apotex Inc. with generics of its antidepressant Paxil under a $480 million antitrust settlement despite promising that only Mylan Inc. would sell competing versions, rebuking a lower court for denying Mylan a fair hearing....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.